G31 a registrational trial in advanced HCC
Latest Information Update: 01 Aug 2023
At a glance
- Drugs GNOS PV02 (Primary)
- Indications Liver cancer
- Focus Registrational; Therapeutic Use
- Sponsors Geneos Therapeutics
- 01 Aug 2023 New trial record
Latest Information Update: 01 Aug 2023